Skip to main content
Clinical Trials/NCT05255939
NCT05255939UnknownNot Applicable

Decrease Artery Occlusion by Distal Radial Arterial Cannulation in ACS Patients

Shenzhen People's Hospital1 site in 1 country1,500 target enrollmentStarted: March 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
1,500
Locations
1
Primary Endpoint
Forearm radical occlusion

Study Overview

Brief Summary

The site of arterial access for coronary angiography and intervention has been the focus of research for decades as it is the source of major complications. Transradial access (TRA) reduces complications among patients undergoing percutaneous coronary procedures but is reported with the complication of radial artery occlusion (RAO) that limits the radial artery for future needs.

Distal radial access (dTRA) has recently gained global popularity as an alternative access route for vascular procedures. Among the benefits of dTRA are the low risk of entry site bleeding complications, the low rate of radial artery occlusion, and improved patient and operator comfort.

This study aims to reveal the feasibility and safety of dTRA and routine TRA procedures in acute coronary syndrome patients. The primary endpoints are forearm radical occlusion rate and major adverse cardiovascular events (MACEs) in the two groups, respectively. Investigators will also focus on puncture success in diagnostic and interventional cases, rate of One attempt success, access time, procedure time, crossover rate, contrast dose of patients, fluoroscopy time and dose, and healthcare cost of each group.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •presence of a pulse in the snuffbox

Exclusion Criteria

  • •Absence of pulse
  • •Ultrasound indication of arterial occlusion or severe calcification
  • •Severe forearm artery malformation
  • •Patients with severe liver and renal failure, or abnormal coagulation function
  • •Established cardiogenic shock
  • •History of previous coronary artery bypass grafting and radial artery use.
  • •Raynaud's disease in the medical history

Arms & Interventions

dTRA group

Experimental

Investigators perform percutaneous coronary intervention by dTRA

Intervention: distal TRA group (Procedure)

TRA group

Other

Investigators perform percutaneous coronary intervention by conventional TRA

Intervention: conventional TRA group (Procedure)

Outcomes

Primary Outcomes

Forearm radical occlusion

Time Frame: during procedure

Doppler ultrasound to determine whether patients suffer forearm radial occlusion

MACEs

Time Frame: during procedure

Major Adverse Cardiovascular Events, including cardiovascular death, myocardial infarction and heart failure.

Secondary Outcomes

  • The total cost in hospitalization(up to 2 years)
  • Procedure time(during procedure)
  • Contrast dose(during procedure)
  • Rate of One attempt success(during procedure)
  • Access time(during procedure)
  • Fluoroscopy dose(during procedure)
  • hand hematoma(during procedure)
  • Crossover rate(during procedure)

Investigators

Sponsor
Shenzhen People's Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials